Co-founder, President and CEO
Benjamin Jackson co-founded Quartesian LLC in January 2003. As president and CEO, Mr. Jackson is responsible for defining the strategic direction of the company and overseeing Quartesian’s unique global business model that maximizes value for the customer through the optimal use of global resources. He has identified niche markets and with the senior management of Quartesian, has been able to effectively manage Quartesian’s global assets such that Quartesian has realized double-digit growth in revenue annually with steady margins since its formation.
Mr. Jackson is a 25 year veteran of the biopharmaceutical industry. He has held management positions at a number of major pharmaceutical companies in statistical programming, clinical data management, and eClinical technologies. He achieved dramatic improvements in quality, efficiency and performance in clinical data management and statistical programming through the introduction of new systems, processes, data models and programming standards across multi-national sites.
Mr. Jackson has an MS in Computer Science from Villanova University, Villanova PA, USA and a BBA in Statistics with a Minor in Economics and Econometrics from Temple University, Philadelphia PA, USA. He has written numerous articles and has spoken at professional meetings on a number of topics relating to clinical data management, statistical programming and eClinical technologies.
Soumitra S Chowdhury
Co-founder and COO
Soumitra Chowdhury was the lead in building Quartesian’s center of excellence in Bangalore, India. He developed an integrated recruiting and training process to build a team of world-class clinical SAS® programmers, data analysts, data managers, data entry technicians and medical writers in Bangalore. Based on his knowledge of the local universities and market, Quartesian hires premium talent who are trained in role-based modules that cover technical aspects of statistical programming and data management as well as the clinical trial process, ICH and 21CFR and current best practices in clinical data interchange and standards. He has been instrumental in developing clinical trial subject matter expert trainers, corporate-wide standardized processes, controls and workflows that differentiate Quartesian from its competitors. He is the chief architect of Quartesian’s onshore/offshore hybrid model that utilizes the talent pool across the USA, Europe and Asia in an optimal mix coordinated by technical project management in the USA. His efforts have led to many satisfied clients and repeat business.
Mr. Chowdhury has 15 years of experience in pharmaceutical and market research. He has held senior positions in project management, data management, statistical programming, application development, data analysis and research.
Mr. Chowdhury has a Bachelor of Commerce and a Master of Commerce from the University of Calcutta and an MBA in management information systems from the Northern Illinois University. He is active in promoting education in clinical data management and statistical programming around the world through Quartesian’s Linkedin® Groups and other outlets. He is also active in professional organizations and societies that promote clinical data management technology and data interchange standards.
Vladimir Mats, Ph.D.
Co-founder and CSO
Dr. Vladimir Mats is responsible for all statistical analyses, consulting and content of statistical reports and deliverables as well as pharmacokinetic analyses and clinical study reports. Dr. Mats built Quartesian’s Ukraine office utilizing his knowledge of the Ukrainian business environment and technological landscape. Through his associations with Ukrainian universities, Quartesian was successful in recruiting mathematics, computer science and engineering graduates and training them in statistical, pharmacokinetic and eClinical application programming in addition to transferring knowledge of the clinical trial process and clinical data domain. Today this office produces a large volume of high-quality statistical analyses plans, statistical analyses and supporting tables, listings and figures as well as novel statistical programming such as simulations, PK/PD analyses and graphics. Dr. Mats’ knowledge of the Central and Eastern European Region and the alliance partner relationships he has made with local CROs enables Quartesian to offer clients a full scope of CRO services and guidance when conducting studies in this region.
Dr. Mats has 15 years of experience in statistical analysis of pre-clinical and clinical trial data in academia, pharmaceutical and medical device industries. He has managed statistics, programming and data management groups in NDA preparation. His specialties include statistical consulting in PK analysis and experimental design.
Dr. Mats has an M.S. in Mathematics from Kharkov State University, Kharkov, Ukraine and Ph.D. and M.S. degrees in Statistics from the University of Maryland. He has provided content for Webinars illustrating novel statistical techniques in clinical research. He has certification in lean six sigma black belt and has done training in statistical quality control in the medical device industry and at the US FDA.
John M. Xavier
Co-founder and CIO
Mr. John M. Xavier is an expert in IT processes related to clinical data services. Mr. Xavier has 16 years of experience in clinical informatics, biometrics, system administration and application development related to eClinical technologies.
Mr. Xavier is the architect of Quartesian’s global IT infrastructure and is responsible for keeping Quartesian current with the emerging technologies.
Mr. Xavier oversees all IT system administration, software licenses and installations, IT system quality assurance, IT system security, eClinical application development, and cloud computing. Mr. Xavier is also responsible for Quartesian’s web and social media presence.
Mr. Xavier is leading Quartesian’s IT process improvement, eClinical technologies and big data analytics initiatives. As an added responsibility he manages the biometrics team in India.
Mr. Xavier has a Bachelors in Engineering from Chennai University, India and has certifications from Microsoft and Oracle.
Aparna Chowdhury [Tanya], CISA
Chief Audit & Compliance Officer
As the Chief Audit and Compliance Officer, Global Head of Quality Assurance, Tanya oversees GCP quality, Regulatory Compliance and manages compliance with Contracts life-cycle. She also manages the Annual Internal Audits, Vendor Qualification and handles External Audits.
Ms. Chowdhury has more than 19 years of experience in Corporate/Internal auditing, Operational Risk Management, Regulatory Compliance and Internal Control experience in Clinical Research, Financial, Securities, and Retirement Services Industry. She has held senior management positions and global experience in quality management with demonstrated ability to successfully lead cross-functional and international teams. She has been extensively involved with planning, managing, and leading Operational, Information Security, Computer System Validation and Compliance audits within a GCP/COSO/COBIT/risk-based framework along with SSAE16 SOC 2 Type 2 audits.
She has a strong background in managing Corrective and Preventive Action [CAPA] enterprise-wide; managing globally Business Continuity Plan/Disaster Recovery/Business Impact Analysis; conducting IT & Security audits as per industry standards and has been heavily involved in SDLC processes as a Subject Matter Expert.
Ms. Chowdhury holds a Bachelor’s Degree in Science with Honors degree in Mathematics along with Business Administration. She is a Certified Information System Auditor [CISA] and is a member of ISACA [Information Systems Audit and Control Association]. She also has training certifications in Project Management, CISSP [Certified Information Systems Security Professional] and IT Audits from Accredited Schools.
Senior Vice President Business Development and Commercial Strategy
As SVP Business Development and Commercial Strategy, Stephen handles all aspects of customer business development including capability presentations, bid proposals and relationship management. He is also responsible for brand and image development as well as securing and maintaining professional relationships with clients, developing early visibility to new projects and business development opportunities, and liaising with technical and operational colleagues at Quartesian to deliver quality on-time services to our clients. Stephen combines more than 30 years of life science industry experience and dedicated technology expertise with a record of success on the clinical data management and systems side as well as growing startup organizations through sales and marketing leadership.
Mr. Boccardo joined Quartesian from Clinical Ink where he served as Chief Commercial Officer. In this role, he was responsible for all Clinical Ink global sales and marketing activities to drive market adoption of the company’s industry-leading eSource products and solutions. Prior to that, he was at BioClinica, where he served as Senior Vice President, Global Business Development for the company’s eClinical Solutions Division. In this role, he achieved triple-digit growth from new customer sales and spearheaded European growth by establishing and leading regional business development teams. Prior to BioClinica, Stephen held various roles in sales and executive management at Liquent, Inc. and served as Vice President of Information Services for Bio-Pharm Clinical Services (OmniCare). He began his career as a clinical programming manager at SmithKline Beecham. Stephen holds a master’s degree in computer science from Villanova University and a bachelor’s degree in mathematics from Ursinus College.
Thomas J. Pillsworth, Jr., M.S., Ph.D.
Senior Vice President, Medical Affairs and Corporate Development
Dr. Pillsworth joined Quartesian in 2010. Dr. Pillsworth’s major responsibilities within Quartesian are threefold. He provides expert advice to clients on their studies and overall program development and ensures that Quartesian’s approach to a study is accurate. Further to this responsibility Dr. Pillsworth conducts in-services on the disease state and interpretation of expected laboratory and other data. He ensures that the short-term and long-term corporate development is consistent with Quartesian’s goals and growth objectives. He also provides “executive” review of projects with constant outward-facing communication with Quartesian’s client sponsors and service provider partners.
Dr. Pillsworth has been in the pharmaceutical industry for 28 years. He has held positions of increasing responsibility in both the business and operational sides in big pharma as well as pre-clinical, confined clinical, and later stage development CROs. His experience and perspective provide a great “value added” proposition for client sponsors.
Dr. Pillsworth holds a B.S. in Biochemistry/Biophysics and an M.S. in Physiology from S.U.N.Y. and a Ph.D. in Pharmacology from the Uniformed Services University of the Health Sciences School of Medicine. He completed a residency/fellowship in Laboratory Medicine at the University of Washington School of Medicine Hospitals. Dr. Pillsworth is an Adjunct Professor in the Department of Biological Sciences and the Department of Chemistry and Biochemistry at the California State University San Marcos and primarily teaches BSN majors.